{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:10:17Z","timestamp":1793419817890,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.tube.2020.102013","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T13:11:57Z","timestamp":1603804317000},"page":"102013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Pyrazinamide resistance and pncA mutations in drug resistant Mycobacterium tuberculosis clinical isolates from Myanmar"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2486-3260","authenticated-orcid":false,"given":"Phyu Win","family":"Ei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8555-623X","authenticated-orcid":false,"given":"Aye Su","family":"Mon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Mi","family":"Htwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Mon","family":"Win","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay Thi","family":"Aye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai Lai","family":"San","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni Ni","family":"Zaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wint Wint","family":"Nyunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaw","family":"Myint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5780-4961","authenticated-orcid":false,"given":"Wah Wah","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2020.102013_bib1","series-title":"Global tuberculosis report 2019","author":"WHO","year":"2019"},{"key":"10.1016\/j.tube.2020.102013_bib2","series-title":"Annual report 2016June","author":"Myanmar","year":"2018"},{"issue":"9","key":"10.1016\/j.tube.2020.102013_bib3","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1128\/JCM.01594-08","article-title":"Sputum PCR-single-strand conformational polymorphism test for same-day detection of pyrazinamide resistance in tuberculosis patients","volume":"47","author":"Sheen","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2020.102013_bib4","author":"WHO"},{"issue":"1","key":"10.1016\/j.tube.2020.102013_bib5","first-page":"147","article-title":"Simple pyrazinamidase and urease tests for routine identification of mycobacteria","volume":"109","author":"Wayne","year":"1974","journal-title":"Am Rev Respir Dis"},{"issue":"10","key":"10.1016\/j.tube.2020.102013_bib6","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1128\/AAC.00630-11","article-title":"Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses","volume":"55","author":"Chang","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.tube.2020.102013_bib7","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/jac\/dkg446","article-title":"Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid","volume":"52","author":"Zhang","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.tube.2020.102013_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01819-14","article-title":"Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study","volume":"5","author":"Miotto","year":"2014","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.tube.2020.102013_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/JCM.01903-13","article-title":"Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China","volume":"52","author":"Tan","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.tube.2020.102013_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01984-17","article-title":"Pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Myanmar","volume":"62","author":"Aung","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.tube.2020.102013_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5588\/ijtld.11.0445","article-title":"Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis","volume":"16","author":"Smith","year":"2012","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.tube.2020.102013_bib12","first-page":"95","article-title":"BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT","volume":"41","author":"Hall","year":"1999","journal-title":"Nucl Acids Symp"},{"issue":"9","key":"10.1016\/j.tube.2020.102013_bib13","doi-asserted-by":"crossref","first-page":"e0511","DOI":"10.1128\/AAC.00511-17","article-title":"Pyrazinamide susceptibility and pncA mutation profiles of mycobacterium tuberculosis among multidrug-resistant tuberculosis patients in Bangladesh","volume":"61","author":"Rahman","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.tube.2020.102013_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1186\/s12879-017-2761-6","article-title":"Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China","volume":"17","author":"Pang","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tube.2020.102013_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tube.2017.12.007","article-title":"Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia","volume":"109","author":"Bwalya","year":"2018","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.tube.2020.102013_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1471-2180-10-223","article-title":"Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand","volume":"10","author":"Jonmalung","year":"2010","journal-title":"BMC Microbiol"},{"issue":"2","key":"10.1016\/j.tube.2020.102013_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1183\/09031936.00033010","article-title":"Treatment of tuberculosis: update 2010","volume":"37","author":"Yew","year":"2011","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.tube.2020.102013_bib18","first-page":"41","volume":"1","author":"Clancy","year":"2008","journal-title":"DNA transcription Nature Education"},{"issue":"3","key":"10.1016\/j.tube.2020.102013_bib19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/AAC.41.3.540","article-title":"Characterization of pncA mutations in pyrazinamide-resistant","volume":"41","author":"Scorpio","year":"1997","journal-title":"Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1016\/j.tube.2020.102013_bib20","first-page":"e34","article-title":"Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis","volume":"2","author":"Zhang","year":"2013","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.tube.2020.102013_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.meegid.2013.06.008","article-title":"Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene","volume":"19","author":"Bhuju","year":"2013","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.tube.2020.102013_bib22","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1128\/JCM.02532-16","article-title":"Non pncA gene-mutated but pyrazinamide resistant Mycobacterium tuberculosis, why is that?","volume":"55","author":"Werngren","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.tube.2020.102013_bib23","first-page":"1","article-title":"Mechanisms of pyrazinamide action and resistance","volume":"2","author":"Zhang","year":"2013","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.tube.2020.102013_bib24","author":"WHO and FIND"},{"issue":"7","key":"10.1016\/j.tube.2020.102013_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133869","article-title":"A global perspective on pyrazinamide resistance: systematic review and meta-analysis","volume":"10","author":"Whitfield","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2020.102013_bib26","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2147\/IDR.S222943","article-title":"Resistance to first-line antituberculosis drugs and prevalence of pncA mutations in clinical isolates of Mycobacterium tuberculosis from Zunyi, Guizhou province of China","volume":"12","author":"Cao","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.tube.2020.102013_bib27","series-title":"Characterization of streptomycin and pyrazinamide resistance in clinical multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar","author":"Oo","year":"2018"},{"issue":"10","key":"10.1016\/j.tube.2020.102013_bib28","first-page":"e86","article-title":"Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates","volume":"6","author":"Huy","year":"2017","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.tube.2020.102013_bib29","doi-asserted-by":"crossref","DOI":"10.3201\/eid2303.161034","article-title":"pncA gene mutations associated with pyrazinamide resistance in drug-resistant tuberculosis, South Africa and Georgia","volume":"23","author":"Allana","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.tube.2020.102013_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5588\/ijtld.11.0266","article-title":"Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis [Short communication]","volume":"16","author":"Pierre-Audigier","year":"2012","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.tube.2020.102013_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-017-4146-z","article-title":"A multiple genome analysis of Mycobacterium tuberculosis reveals specific novel genes and mutations associated with pyrazinamide resistance","volume":"18","author":"Sheen","year":"2017","journal-title":"BMC Genom"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979220301803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979220301803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:46:07Z","timestamp":1761468367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979220301803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"alternative-id":["S1472979220301803"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2020.102013","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrazinamide resistance and pncA mutations in drug resistant Mycobacterium tuberculosis clinical isolates from Myanmar","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2020.102013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102013"}}